Attorney blasts Finra after regulator loses insider trading case

Lawyer says it was 'slimy' of Finra to publicize the case while it was still being litigated

Aug 18, 2017 @ 3:26 pm

By Bruce Kelly

A lawyer for a stock analyst exonerated Wednesday in an insider trading case brought by the Financial Industry Regulatory Authority Inc. slammed the agency for publicizing the case during an industry conference while the case was still being litigated.

In October 2015, Finra's department of enforcement filed a complaint against Matthew J. Dodds, a stock analyst at Citigroup Global Markets, alleging he "selectively disclosed material non-public information" to a hedge fund client "regarding a merger between two publicly-traded medical device companies."

In May 2016, at Finra's annual meeting in Washington, D.C., Finra officials named Mr. Dodds in a PowerPoint presentation during a session about rules affecting research analysts, according to Rob Herskovits, Mr. Dodd's attorney, who questioned Finra naming his client in such a fashion while the lawsuit against him was still pending.

"The claim had just been filed, and they were, frankly, a little slimy," Mr. Herskovits said. "Who does that? These were contested allegations. It would be another thing if it was a completed action. Finra had some broader concern about conduct of research analysts and was pressing the envelope a bit about how they could flex their muscles here. I think it was unfortunate."

Finra's lawsuit against Mr. Dodds was Finra's "trophy case" and the focus of the PowerPoint presentation, he said. "This case highlights the perils of overzealous advocacy by Finra," Mr. Herskovits added. "They brought an action without serious investigation."

"The purpose of the panel was to discuss current topics in the subject matter area, including relevant enforcement actions, all of which are made publicly available by rule," wrote Finra spokeswoman Michelle Ong in an email to InvestmentNews. "The case was merely included as part of a summary of disciplinary actions relevant to the topic of the panel discussion."

Finra alleged Mr. Dodds in early October 2014 tipped off a hedge fund client that, before the market opened the next day, medical technology company Medtronic Inc. would issue a press release reaffirming its commitment to merge with medical device and health care product company Covidien, according to the hearing panel decision. Finra also alleged that Mr. Dodds asked a hedge fund executive to delete a voicemail message that he had left.

A sticking point for the Finra hearing panel was why Mr. Dodds would tip off only one client and not others, according to the decision.

"We find that Dodds may have hinted in those four communications that he believed a Medtronic press release was imminent, and he may have conveyed that he believed Medtronic would reaffirm its commitment to merge with Covidien," according to the decision. "Because the evidence does not show that Dodds communicated material, non-public information in four of the five communications on October 2, 2014, we question why he would have behaved differently in his fifth communication, [with the hedge fund client], and Finra Enforcement has not suggested a logical explanation for such conduct."

The panel also found that Finra enforcement had "insufficient evidence" to support the allegation of the erased voicemail.

This story has been updated to indicate that Finra's department of enforcement filed its complaint against Mr. Dodds in October 2015.

0
Comments

What do you think?

View comments

Recommended for you

Featured video

INTV

Why broker-dealers are on a roll

Deputy editor Bob Hordt and senior columnist Bruce Kelly discuss last year's bounce-back for IBDs.

Latest news & opinion

Top 10 IBDs ranked by revenue

These independent broker dealers generated the most revenues in 2017.

8 podcasts advisers listen to when they aren't working

Listening to podcasts for the fun of it.

UBS continues to cut loans to recruits, while increasing compensation to brokers

The wirehouse reduced recruitment loans 20% and increased bonus loans 68% in the first quarter.

Things are looking up: IBDs soared in 2017

With revenue up, interest rates rising and regulation easing, IBDs are soaring.

SEC advice rule may give RIAs leg up over broker-dealers

Experts say advisers will be able to point to their role as fiduciaries as a differentiator in the advice market.

X

Hi! Glad you're here and we hope you like all the great work we do here at InvestmentNews. But what we do is expensive and is funded in part by our sponsors. So won't you show our sponsors a little love by whitelisting investmentnews.com? It'll help us continue to serve you.

Yes, show me how to whitelist investmentnews.com

Ad blocker detected. Please whitelist us or give premium a try.

X

Subscribe and Save 60%

Premium Access
Print + Digital

Learn more
Subscribe to Print